無料セミナー : 2020年3月4日『Future of Immuno-Oncology 免疫腫瘍学の未来』 DelveInsight Business Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のペプチド治療薬市場および動向と業界予測

Global Peptide Therapeutics Market Analysis & Trends - Industry Forecast to 2027

発行 Accuray Research 商品コード 665599
出版日 ページ情報 英文 184 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
世界のペプチド治療薬市場および動向と業界予測 Global Peptide Therapeutics Market Analysis & Trends - Industry Forecast to 2027
出版日: 2018年07月01日 ページ情報: 英文 184 Pages
概要

当レポートでは、世界のペプチド治療薬市場について調査し、市場の現状と2027年までの成長予測、技術別、APIペプチドタイプ別、投与ルート別、タイプ別、分子タイプ別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 市場概説

第2章 エグゼクティブサマリー

第3章 市場概要

  • 現況
  • 促進因子
  • 阻害因子
  • 業界の魅力

第4章 技術別市場

  • 固相
  • 液相
  • ハイブリッド相

第5章 APIペプチドタイプ別市場

  • CMO
  • インハウス

第6章 投与ルート別市場

  • 経口
  • 非経口
  • 粘膜
  • その他

第7章 タイプ別市場

  • ジェネリック薬
  • 革新薬

第8章 分子タイプ別市場

第9章 用途別市場

  • 中枢神経系
  • 代謝
  • 腎臓
  • 心血管疾患
  • 抗感染
  • 呼吸器
  • 皮膚
  • 消化管
  • 感染病
  • その他

第10章 地域別市場

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東
  • ラテンアメリカ
  • その他

第11章 主要企業の活動

  • 合併・買収
  • 提携・合弁・連携・協定
  • 製品上市・拡充
  • その他

第12章 主要企業

図表

List of Tables

  • Table 1 Global Peptide Therapeutics Market By Region, Market Forecast (2015-2027) (US $MN)
  • Table 2 Global Peptide Therapeutics Market By Technology, Market Forecast (2015-2027) (US $MN)
  • Table 3 Global Peptide Therapeutics Market By Solid Phase, Market Forecast (2015-2027) (US $MN)
  • Table 4 Global Peptide Therapeutics Market By Liquid Phase, Market Forecast (2015-2027) (US $MN)
  • Table 5 Global Peptide Therapeutics Market By Hybrid Phase, Market Forecast (2015-2027) (US $MN)
  • Table 6 Global Peptide Therapeutics Market By API Peptide Type, Market Forecast (2015-2027) (US $MN)
  • Table 7 Global Peptide Therapeutics Market By CMO, Market Forecast (2015-2027) (US $MN)
  • Table 8 Global Peptide Therapeutics Market By In-house, Market Forecast (2015-2027) (US $MN)
  • Table 9 Global Peptide Therapeutics Market By Route of Administration, Market Forecast (2015-2027) (US $MN)
  • Table 10 Global Peptide Therapeutics Market By Oral, Market Forecast (2015-2027) (US $MN)
  • Table 11 Global Peptide Therapeutics Market By Parenteral, Market Forecast (2015-2027) (US $MN)
  • Table 12 Global Peptide Therapeutics Market By Pulmonary, Market Forecast (2015-2027) (US $MN)
  • Table 13 Global Peptide Therapeutics Market By Mucosal, Market Forecast (2015-2027) (US $MN)
  • Table 14 Global Peptide Therapeutics Market By Other Route of Administration, Market Forecast (2015-2027) (US $MN)
  • Table 15 Global Peptide Therapeutics Market By Type, Market Forecast (2015-2027) (US $MN)
  • Table 16 Global Peptide Therapeutics Market By Generic, Market Forecast (2015-2027) (US $MN)
  • Table 17 Global Peptide Therapeutics Market By Innovative, Market Forecast (2015-2027) (US $MN)
  • Table 18 Global Peptide Therapeutics Market By Type of Molecule, Market Forecast (2015-2027) (US $MN)
  • Table 19 Global Peptide Therapeutics Market By Natriuretic, Market Forecast (2015-2027) (US $MN)
  • Table 20 Global Peptide Therapeutics Market By Somatostatin, Market Forecast (2015-2027) (US $MN)
  • Table 21 Global Peptide Therapeutics Market By Immunopeptide, Market Forecast (2015-2027) (US $MN)
  • Table 22 Global Peptide Therapeutics Market By Vasopressin, Market Forecast (2015-2027) (US $MN)
  • Table 23 Global Peptide Therapeutics Market By Calcitonin, Market Forecast (2015-2027) (US $MN)
  • Table 24 Global Peptide Therapeutics Market By Other Type of Molecule, Market Forecast (2015-2027) (US $MN)
  • Table 25 Global Peptide Therapeutics Market By Application, Market Forecast (2015-2027) (US $MN)
  • Table 26 Global Peptide Therapeutics Market By CNS, Market Forecast (2015-2027) (US $MN)
  • Table 27 Global Peptide Therapeutics Market By Metabolic, Market Forecast (2015-2027) (US $MN)
  • Table 28 Global Peptide Therapeutics Market By Renal, Market Forecast (2015-2027) (US $MN)
  • Table 29 Global Peptide Therapeutics Market By CVD, Market Forecast (2015-2027) (US $MN)
  • Table 30 Global Peptide Therapeutics Market By Anti-infective, Market Forecast (2015-2027) (US $MN)
  • Table 31 Global Peptide Therapeutics Market By Cancer, Market Forecast (2015-2027) (US $MN)
  • Table 32 Global Peptide Therapeutics Market By Respiratory, Market Forecast (2015-2027) (US $MN)
  • Table 33 Global Peptide Therapeutics Market By Dermatology, Market Forecast (2015-2027) (US $MN)
  • Table 34 Global Peptide Therapeutics Market By GIT, Market Forecast (2015-2027) (US $MN)
  • Table 35 Global Peptide Therapeutics Market By Infectious Disease, Market Forecast (2015-2027) (US $MN)
  • Table 36 Global Peptide Therapeutics Market By Other Applications, Market Forecast (2015-2027) (US $MN)
  • Table 37 Global Peptide Therapeutics Market By Pain Management, Market Forecast (2015-2027) (US $MN)
  • Table 38 Global Peptide Therapeutics Market By Hematological Disorders, Market Forecast (2015-2027) (US $MN)
  • Table 39 Global Peptide Therapeutics Market By Dermatological Disorders, Market Forecast (2015-2027) (US $MN)

Note: North America, Europe, Asia Pacific, Middle East, Latin America and RoW tables are represented in above manner.

目次

The Global Peptide Therapeutics Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rising occurrences of cardiovascular illnesses

technological enhancement with introduction of hybrid technology, shifting focus toward untapped markets and growth opportunities/investment opportunities.

Based on technology, market is segmented into solid phase, liquid phase and hybrid phase. Depending on API peptide type, market is divided into CMO and in-house.

By route of administration, market is classified into Oral, Parenteral, Pulmonary, Mucosal and Other Route of Administration. On basis of type, market is divided into generic and innovative.

Among type of molecule, market is segmented into natriuretic, somatostatin, immunopeptide, vasopressin, calcitonin and other type of molecule.

Based on application, market is classified into CNS, metabolic, renal, CVD, anti-infective, cancer, respiratory, dermatology, GIT, infectious disease and other applications. Other Applications segment is further sub-segmented into pain management and hematological disorders.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • South Africa
  • Others

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Table of Contents

1 Market Outline

  • 1.1 Research Methodology
    • 1.1.1 Research Approach & Sources
  • 1.2 Market Trends
  • 1.3 Regulatory Factors
  • 1.4 Technology Analysis
  • 1.5 Application Analysis
  • 1.6 Strategic Benchmarking
  • 1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview

  • 3.1 Current Trends
    • 3.1.1 Rising occurrences of cardiovascular illnesses
    • 3.1.2 Technological enhancement with introduction of hybrid technology
    • 3.1.3 Shifting focus toward untapped markets
    • 3.1.4 Growth Opportunities/Investment Opportunities
  • 3.2 Drivers
  • 3.3 Constraints
  • 3.4 Industry Attractiveness
    • 3.4.1 Bargaining power of suppliers
    • 3.4.2 Bargaining power of buyers
    • 3.4.3 Threat of substitutes
    • 3.4.4 Threat of new entrants
    • 3.4.5 Competitive rivalry

4 Market, By Technology

  • 4.1 Solid Phase
    • 4.1.1 Solid Phase Market Forecast to 2027 (US$ MN)
  • 4.2 Liquid Phase
    • 4.2.1 Liquid Phase Market Forecast to 2027 (US$ MN)
  • 4.3 Hybrid Phase
    • 4.3.1 Hybrid Phase Market Forecast to 2027 (US$ MN)

5 Peptide Therapeutics Market, By API Peptide Type

  • 5.1 CMO
    • 5.1.1 CMO Market Forecast to 2027 (US$ MN)
  • 5.2 In-house
    • 5.2.1 In-house Market Forecast to 2027 (US$ MN)

6 Peptide Therapeutics Market, By Route of Administration

  • 6.1 Oral
    • 6.1.1 Oral Market Forecast to 2027 (US$ MN)
  • 6.2 Parenteral
    • 6.2.1 Parenteral Market Forecast to 2027 (US$ MN)
  • 6.3 Pulmonary
    • 6.3.1 Pulmonary Market Forecast to 2027 (US$ MN)
  • 6.4 Mucosal
    • 6.4.1 Mucosal Market Forecast to 2027 (US$ MN)
  • 6.5 Other Route of Administration
    • 6.5.1 Other Route of Administration Market Forecast to 2027 (US$ MN)

7 Peptide Therapeutics Market, By Type

  • 7.1 Generic
    • 7.1.1 Generic Market Forecast to 2027 (US$ MN)
  • 7.2 Innovative
    • 7.2.1 Innovative Market Forecast to 2027 (US$ MN)

8 Peptide Therapeutics Market, By Type of Molecule

  • 8.1 Natriuretic
    • 8.1.1 Natriuretic Market Forecast to 2027 (US$ MN)
  • 8.2 Somatostatin
    • 8.2.1 Somatostatin Market Forecast to 2027 (US$ MN)
  • 8.3 Immunopeptide
    • 8.3.1 Immunopeptide Market Forecast to 2027 (US$ MN)
  • 8.4 Vasopressin
    • 8.4.1 Vasopressin Market Forecast to 2027 (US$ MN)
  • 8.5 Calcitonin
    • 8.5.1 Calcitonin Market Forecast to 2027 (US$ MN)
  • 8.6 Other Type of Molecule
    • 8.6.1 Other Type of Molecule Market Forecast to 2027 (US$ MN)

9 Peptide Therapeutics Market, By Application

  • 9.1 CNS
    • 9.1.1 CNS Market Forecast to 2027 (US$ MN)
  • 9.2 Metabolic
    • 9.2.1 Metabolic Market Forecast to 2027 (US$ MN)
  • 9.3 Renal
    • 9.3.1 Renal Market Forecast to 2027 (US$ MN)
  • 9.4 CVD
    • 9.4.1 CVD Market Forecast to 2027 (US$ MN)
  • 9.5 Anti-infective
    • 9.5.1 Anti-infective Market Forecast to 2027 (US$ MN)
  • 9.6 Cancer
    • 9.6.1 Cancer Market Forecast to 2027 (US$ MN)
  • 9.7 Respiratory
    • 9.7.1 Respiratory Market Forecast to 2027 (US$ MN)
  • 9.8 Dermatology
    • 9.8.1 Dermatology Market Forecast to 2027 (US$ MN)
  • 9.9 GIT
    • 9.9.1 GIT Market Forecast to 2027 (US$ MN)
  • 9.10 Infectious Disease
    • 9.10.1 Infectious Disease Market Forecast to 2027 (US$ MN)
  • 9.11 Other Applications
    • 9.11.1 Other Applications Market Forecast to 2027 (US$ MN)
      • 9.11.1.1 Pain Management
      • 9.11.1.1.1 Pain Management Market Forecast to 2027 (US$ MN)
      • 9.11.1.2 Hematological Disorders
      • 9.11.1.2.1 Hematological Disorders Market Forecast to 2027 (US$ MN)

10 Peptide Therapeutics Market, By Geography

  • 10.1 North America
    • 10.1.1 North America Market Forecast by Countries to 2027 (US$ MN)
      • 10.1.1.1 US
      • 10.1.1.2 Canada
      • 10.1.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 Europe Market Forecast by Countries to 2027 (US$ MN)
      • 10.2.1.1 Germany
      • 10.2.1.2 U.K
      • 10.2.1.3 Italy
      • 10.2.1.4 France
      • 10.2.1.5 Spain
      • 10.2.1.6 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
      • 10.3.1.1 China
      • 10.3.1.2 Japan
      • 10.3.1.3 India
      • 10.3.1.4 Australia
      • 10.3.1.5 New Zealand
      • 10.3.1.6 Rest of Asia Pacific
  • 10.4 Middle East
    • 10.4.1 Middle East Market Forecast by Countries to 2027 (US$ MN)
      • 10.4.1.1 Saudi Arabia
      • 10.4.1.2 UAE
      • 10.4.1.3 Rest of Middle East
  • 10.5 Latin America
    • 10.5.1 Latin America Market Forecast by Countries to 2027 (US$ MN)
      • 10.5.1.1 Argentina
      • 10.5.1.2 Brazil
      • 10.5.1.3 Rest of Latin America
  • 10.6 Rest of the World (RoW)
    • 10.6.1 RoW Market Forecast by Countries to 2027 (US$ MN)
      • 10.6.1.1 South Africa
      • 10.6.1.2 Others

11 Key Player Activities

  • 11.1 Acquisitions & Mergers
  • 11.2 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.3 Product Launch & Expansions
  • 11.4 Other Activities

12 Leading Companies

  • 12.1 Amgen Inc.
  • 12.2 Takeda Pharmaceutical Company Limited
  • 12.3 Lonza Inc.
  • 12.4 AstraZeneca PLC
  • 12.5 Bristol-Myers Squibb(BMS)
  • 12.6 Pfizer Inc.
  • 12.7 Sanofi
  • 12.8 Teva Pharmaceutical
  • 12.9 Bachem Holding AG
  • 12.10 Eli Lilly and Company
  • 12.11 Novartis AG
  • 12.12 Glaxosmithkline (GSK)
  • 12.13 Novo Nordisk A/S
Back to Top